🔎 Trials Near Me

Dachaigh › Galar Alzheimer › North Carolina

Sgrùdaidhean clionaigeach Galar Alzheimer ann an North Carolina

Tha 21 sgrùdaidhean airson Galar Alzheimer a’ lorg phàirtichean aig làraichean ann an North Carolina.

Bailtean ann an North Carolina

Teacsa sgrùdaidh oifigeil (Beurla)

A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

  • New Hope Clinical Research, Charlotte
  • AMC Research, LLC, Matthews
A’ fastadhÌre 2
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT06540833

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

  • West Clinical Research, Morehead City
A’ fastadhÌre 3
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06937229

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  • Triad Clinical Trials - 515 College Rd, Greensboro
  • AMC Research, LLC - Flourish - PPDS, Matthews
  • West Clinical Research, Morehead City
A’ fastadhÌre 3
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06585787

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  • Triad Clinical Trials, Greensboro
A’ fastadhÌre 3
Aoisean 50 gu 90 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07177352

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease

  • West Clinical Research, Morehead City
A’ fastadhÌre 3
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07011745

ADRC Clinical Cohort (Alzheimer's Disease)

  • Duke University, Durham
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 25 gu 80 · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06703541

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

  • New Hope Clinical Research, Charlotte
  • UNC Health REX Hospital, Raleigh
A’ fastadhÌre 2
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

  • AMC Research, LLC ( Site 1006), Matthews
A’ fastadhÌre 2
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07033494

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

  • Duke University, Durham
A’ fastadhÌre 1
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT06297590

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

  • AMC Research, LLC, Matthews
A’ fastadhÌre 3
Aoisean 60 gu 85 · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT06976216

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • Duke University Medical Center, Durham
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT06563895

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

  • Flourish Research, Matthews
A’ fastadhÌre 1/2
Aoisean 35 gu 85 · Gach gnè · Air ùrachadh 10 Iuch 2026 · NCT05462106

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  • Monroe Biomedical Research, Monroe
A’ fastadhÌre 3
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  • UNC Hosp Invest Drug Serv Pharm, Chapel Hill
A’ fastadhÌre 2
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 26 Ògmh 2026 · NCT07094516

Olfactory Biopsies

  • Duke University Health Center, Durham
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Ògmh 2026 · NCT07021040

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

  • Duke Early Phase Research Unit, Durham
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 45 gu 85 · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT06657768

Late Onset Alzheimer's Disease

  • North Carolina State University, Raleigh
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT05010603

Connect-Home: Alzheimer's Disease and Related Dementias

  • University of North Carolina at Chapel Hill, Chapel Hill
A’ fastadh
Aoisean 19 agus nas sine · Gach gnè · Air ùrachadh 30 Màrt 2026 · NCT06840587

Wake Forest Alzheimer's Disease Clinical Core

  • Wake Forest Baptist Health, Winston-Salem
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 27 Màrt 2026 · NCT03140865

Retinal Imaging in Neurodegenerative Disease

  • Duke University Medical Center, Durham
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Gearr 2026 · NCT03233646

Open-label Extension Study in Participants With Early Alzheimer's Disease

  • GSK Investigational Site, Matthews
A’ fastadhÌre 2
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 2 Gearr 2026 · NCT07105709

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.